[MPTP and Parkinson's disease].
Imai
H
H
Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000818:Animals; D001921:Brain / Q000473:pathology; D015198:Designer Drugs; D004195:Disease Models, Animal; D006801:Humans; D008252:Macaca fascicularis; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D011725:Pyridines / Q000633:toxicity; D019966:Substance-Related Disorders
D015198:Designer Drugs; D011725:Pyridines; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine